Ocugen Inc. sell shadow
Start price
09.02.21
/
0%
€13.20
Target price
09.02.22
-
Performance (%)
-73.73%
End price
10.02.22
€3.47
Summary
This prediction ended on 10.02.22 with a price of €3.47. The SELL prediction by shadow for Ocugen Inc. performed very well with a performance of -73.73%. This prediction was marked as speculative and is excluded from shadow's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ocugen Inc. | 2.074% | 2.074% | 192.762% | -81.396% |
iShares Core DAX® | 1.560% | 4.721% | 18.671% | 17.397% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% | 35.896% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% | 10.295% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% | 38.843% |
According to shadow what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by shadow for this prediction
In the thread Ocugen Inc. diskutieren
Sell Ocugen Inc.
In the thread Trading Ocugen Inc.
Die von shadow gewählte maximale Laufzeit wurde überschritten